Officers	Members
James G. Culp. BS, MA Chairman Term: 2010-2012 Consultant, National Advisory Committee on Rural Health of DHHS, McKing Consulting Corp.; formerly served in Deputy Director, Office of Rural Health Policy, National Eye Institute and HCFA/DHHS; National Cancer Institute; NIH Harold A. Cohen, PhD Secretary/Treasurer Consumer Representative Term: 2010-2012 President of Hal Cohen, Inc., a health care consulting firm. Past Executive Director of Maryland Health Services Cost Review Commission (HSCRC) and past member of Prospective Payment Assessment Commission (ProPAC).	Michelle A. Gourdine, MD Term: 2010-2012 CEO and Principal Consultant, Michelle Gourdine and Associates, LLC; Clinical Assistant Professor of Pediatrics and Epidemiology/Preventive Medicine, University of Maryland School of Medicine; Senior Associate, Johns Hopkins Bloomberg School of Public Health Robert J. Lanza, Jr. Term: 2008-2010 Executive Administrator, Genesis Healthcare Corporation, Salisbury Rehabilitation and Nursing Center Paul E. Martin, MA, MS Term: 2010-2012 Robert L. Moore, CPA Term: 2010-2012 Fadia T. Shaya, PhD., MPH Term: 2008-2010 Associate Professor, Pharmaeconomics and Outcomes Research, School of Pharmacy, University of Maryland; Epidemiology and Preventive Medicine, School of Medicine, University of Maryland; Associate Director, Center on Drugs and Public Policy, School of Pharmacy, University of Maryland; Lecturer, the Johns Hopkins Bloomberg School of Public Health Catherine N. Smoot-Haselnus, MD Term: 2010-2012 Founder and President, Chesapeake Eye Center Paul Schwab, MA, MPA Term: 2009-2011 Independent consultant; Former Executive Director of Association of Organ Procurement Organizations; Served earlier as Deputy Administrator, Substance Abuse and Mental Health Services Administration (HHS) and as Deputy Director, Bureau of Health Professions, HRSA (HHS) Tiffany A. Tate, BS, MHS Term: 2009-2011 Public Health Consultant; Former Coordinator, Immunization Action Program, Baltimore County Department of Health; Former Research Associate and Project Director, Johns Hopkins Women, Infants and Children (WIC) Program
The maximum size of the Board will not exceed 15 members. The term of office of each Trustee shall be no longer than three (3) years; said Trustees shall serve staggered terms. A Trustee may serve a maximum of two (2) three (3) year terms, for a total of six (6) years. Members are seated January 1 of each year. Typically one third of the Board is appointed each year. The Board of Trustees meet quarterly. Compensation is $450.00 per meeting. Last Updated: March 3, 2010

Officers

Members

James G. Culp. BS, MA
Chairman
Term: 2010-2012

Consultant, National Advisory Committee on Rural Health of DHHS, McKing Consulting Corp.; formerly served in Deputy Director, Office of Rural Health Policy, National Eye Institute and HCFA/DHHS; National Cancer Institute; NIH

Harold A. Cohen, PhD
Secretary/Treasurer
Consumer Representative
Term: 2010-2012

President of Hal Cohen, Inc., a health care consulting firm. Past Executive Director of Maryland Health Services Cost Review Commission (HSCRC) and past member of Prospective Payment Assessment Commission (ProPAC).

Michelle A. Gourdine, MD
Term: 2010-2012
CEO and Principal Consultant, Michelle Gourdine and Associates, LLC; Clinical Assistant Professor of Pediatrics and Epidemiology/Preventive Medicine, University of Maryland School of Medicine; Senior Associate, Johns Hopkins Bloomberg School of Public Health

Robert J. Lanza, Jr.
Term: 2008-2010
Executive Administrator, Genesis Healthcare Corporation, Salisbury Rehabilitation and Nursing Center

Paul E. Martin, MA, MS
Term: 2010-2012

Robert L. Moore, CPA
Term: 2010-2012

Fadia T. Shaya, PhD., MPH
Term: 2008-2010
Associate Professor, Pharmaeconomics and Outcomes Research, School of Pharmacy, University of Maryland; Epidemiology and Preventive Medicine, School of Medicine, University of Maryland; Associate Director, Center on Drugs and Public Policy, School of Pharmacy, University of Maryland; Lecturer, the Johns Hopkins Bloomberg School of Public Health

Catherine N. Smoot-Haselnus, MD
Term: 2010-2012
Founder and President, Chesapeake Eye Center

Paul Schwab, MA, MPA
Term: 2009-2011
Independent consultant; Former Executive Director of Association of Organ Procurement Organizations; Served earlier as Deputy Administrator, Substance Abuse and Mental Health Services Administration (HHS) and as Deputy Director, Bureau of Health Professions, HRSA (HHS)

Tiffany A. Tate, BS, MHS
Term: 2009-2011
Public Health Consultant; Former Coordinator, Immunization Action Program, Baltimore County Department of Health; Former Research Associate and Project Director, Johns Hopkins Women, Infants and Children (WIC) Program

The maximum size of the Board will not exceed 15 members. The term of office of each Trustee shall be no longer than three (3) years; said Trustees shall serve staggered terms. A Trustee may serve a maximum of two (2) three (3) year terms, for a total of six (6) years. Members are seated January 1 of each year. Typically one third of the Board is appointed each year. The Board of Trustees meet quarterly. Compensation is $450.00 per meeting.

Last Updated: March 3, 2010